Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology

Ítems similars

• Exploiting DNA Damage Response in the Era of Precision Oncology
  Publicat: (2020)
• The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response—Biological and Clinical Aspects
  per: Michaela Medová, et al.
  Publicat: (2013-12-01)
• The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response — Biological and Clinical Aspects
  per: Medová, Michaela, et al.
  Publicat: (2013)
• Editorial: Cancer-Associated Defects in the DNA Damage Response: Drivers for Malignant Transformation and Potential Therapeutic Targets
  per: van Vugt, Marcel A. T. M., et al.
  Publicat: (2015)
• Editorial: Precision Medicine in Oncology
  per: Re, Angela, et al.
  Publicat: (2018)